Trying To Quit Smoking? This Show Is For You
Nothing’s quite as easy as becoming a smoker. A large part of that is because of the denial. You convince yourself you’re not a smoker if you just have a cigarette occasionally. You’re totally in control, you could stop whenever you want, you tell your friends and yourself. Only when you decide to stop, do you realize that there are few things more difficult than trying to quit smoking. Even after years of struggle and abstaining, it takes just a second for it all to go up in a puff. Literally. Many just give up trying because it all seems so hopeless.
Nicotex decided to ignite a spark of hope with their #ICanYouCan campaign. They encouraged and supported smokers trying to quit by starting online discussions and conversations about quitting, got celebrities who have quit smoking to speak up about their struggle, asked quitters to come forward and share their stories. Those trying to quit could finally see that others too have struggled for years till they finally overcome their personal Everest.
It didn’t stop there. Nicotex took the 6 most inspiring stories and gave those quitters a chance to climb Mount Everest. That’s the unique premise of the Nicotex ‘I Can You Can’ show that launches this Sunday on National Geographic Channel and Viu. On this 6-episode show, 6 participants will try to climb Mount Everest, while trying to conquer their personal uphill goal of quitting smoking. Out of the 6, three have already quit smoking, while the other three are trying to stop. ‘I Can You Can’ is hosted by Milind Soman, who himself quit smoking a long time ago.
This pack of quitters will start their journey from Kathmandu, make their way to the Everest Base Camp and from there climb up to Kala Patthar. It’s an arduous expedition but climbing Everest is not just about the destination, it’s about the mindset. It’s a lot like quitting smoking, you don’t know if you’ll succeed or if you’ll give up half-way. Only those who give it their all can conquer it, but when they do, they go on to become an inspiration to others. Watch a sneak preview of the show below.
Will this bunch of quitters be able to make it? Tune-in to National Geographic Channel at 7pm this Sunday or log on to Viu to watch their inspiring journey.
This article originally appeared on The Quint
Read it now
Cipla Q3 FY18 Results Reflect Continuously Improving Quality Of Earnings Backed By Strong Momentum Across Key Regions
Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its unaudited consolidated financial results for the quarter ended December 31, 2017. The Company reported quarterly revenues of Rs 3,914 crores, a growth of 7% on a year-on-year basis, with EBITDA at 20.9%, growing 21% on a year-on-year basis. EBITDA margins have been improving continuously driven by cost optimization across all spend lines despite R&D getting stepped up to 7.6% of sales during the quarter. When adjusted for the one-offs during the quarter, the Profit After Tax rose by ~25% on a year-on-year basis. The Company reported healthy growth across businesses in India, South Africa, API, Europe and Sub-Saharan Africa markets.
“This has been one of our better quarters. Key performance metrics look healthy and are inline
with the internal targets we set for ourselves. We are stepping up our investments in R&D
which has resulted in approvals for differentiated products in the US”
– Umang Vohra
MD and Global CEO, Cipla Ltd
Download the PDF.
Programme On Nutritious Food Organised By Cipla
Samala Hema, Seethaphalmandi Corporator attended the programme about nutritious food organised by Cipla industries at Jyothi Model High School, here on Wednesday. As a part of the programme, experts from the health industry held a session to explain parents’ about child health and immunity.
The corporator too encouraged children and the parents to adopt a hygienic and healthy lifestyle to protect young lives. Later, the corporator along with officials of the GHMC and senior TRS leaders comprising Laxman Rao, ward member of the constituency interacted with the residents of Beedal Basthi as a part of the Basthi Baata programme to know their problems.
Adequate nutrition is an important aspect of a healthy lifestyle. Attended the “Nutrition Awareness” drive organised by Cipla at Jyothi model school & explained the importance of maintaining food nutritive value to students and parents. pic.twitter.com/WDQc6sxn20
— Hema Samala (@hema_samala) January 31, 2018
This article originally appeared in The Hans India.
Cipla Receives Final Approval for a Generic Version of Gilead’s Viread®
Cipla Ltd, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Tenofovir Disoproxil Fumarate Tablets, 300mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Gilead Sciences’ Viread® Tablets, 300mg.
Cipla’s Tenofovir Disoproxil Fumarate Tablets, 300mg, are AB-rated generic equivalents of Gilead Sciences’ Viread® Tablets, 300mg, and are indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in adults and paediatric patients 12 years of age and older. Cipla is excited to add this important antiretroviral product to its growing portfolio of ARVs in the U.S.
The product will be available for commercial shipment in the U.S. immediately. Viread® Tablets,
300mg, had U.S. sales of approximately $725M for the 12-month period ending November 2017,
as reported by IMS Health.
India’s Cancer Cases Far Lower Than Those In The West, Yet Death Rate Higher
India’s cancer graphs tell two distinct stories. The first holds out hope as India’s cancer incidence is far lower than developed nations such as Denmark and the US. If cancer strikes over 300 out of every 100,000 population in Denmark, the corresponding number in India hovers around 80. But the second Indian cancer story is worrisome: cancer manages to get the upper hand in almost 70% of cases in India. A study in the medical journal, The Lancet, in 2014 indicated only 30% of India’s cancer patients survive for over five years.
So while India has lower cancer rates than many other countries, it has a high death rate. Check the World Health Organisation’s Globocan 2012 report’s analysis for breast cancer: only 1 out every 5 or 6 women newly diagnosed with breast cancer died in the US, but corresponding figures in India stood at 1out of every 2 patients.
Experts said early detection could go a long way in reducing the high death rate caused due to illiteracy, fear and taboos. “In India, almost 50% of all cancers are seen in late stages. This is the reason our death rate is higher than western countries,” said senior medical oncologist Shona Nag.
Maximum cancer patients succumb to lung, head and neck and breast cancers. “We lose almost 80% of all patients detected with lung cancer. The death rate due to breast cancer world over is 20%, but we lose over 50% of our breast cancer patients,” Nag said.
Almost 80% of cervical cancer patients are diagnosed in stage 3-4 in India, but the West has almost eradicated this cancer due to regular pap smear tests. Given India’s population, it is impossible to scan everybody. “Self-breast exams and clinical exams involving community workers or ancillary health professionals are hence crucial,” she added.
Lack of awareness is the main cause for late detection. “In the western world, the culture is openness and they are more aware. Though we have facilities, we cannot reach out to such a huge population. Almost all cancers are detected at late stage in India mainly because of lack of awareness and social stigma,” said medical oncologist Anantbhushan Ranade.
Cancer surgeon Anupama Mane said, “We have women with 10cm lumps who come to us late because the lump didn’t hurt or cause pain so they did not think a check was needed.” Moreover, men don’t discuss women’s health. “So a blood stain or excessive bleeding is dismissed and not taken up as cause for worry,” Mane said. Early detection is key to reduce mortality. “It is important to diagnose cancer early because then you have a chance at curing it. The spread and extent of it make it harder to control,” said oncosurgeon Snita Sinukumar. Lack of a dedicated health care system is one of the big reasons for higher deaths. “Just like Aadhar, we need to make it compulsory to invest in one’s own healthcare,” Sinukumar added.
This article originally appeared on The Times of India